These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15624554)

  • 1. Updated classification of hemangiomas and other vascular anomalies.
    Chang MW
    Lymphat Res Biol; 2003; 1(4):259-65. PubMed ID: 15624554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular tumors and vascular malformations: evidence for an association.
    Garzon MC; Enjolras O; Frieden IJ
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):275-9. PubMed ID: 10642685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of vascular anomalies: classification into three categories based upon clinical and biochemical characteristics.
    Chiller KG; Frieden IJ; Arbiser JL
    Lymphat Res Biol; 2003; 1(4):267-81. PubMed ID: 15624555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic study of pediatric vascular anomalies: a report of 117 cases].
    Niu HL; Zhou SY; Lin QQ; Yi P; Wang FH; Gao Q; Chen ZR; Xia JQ; Zheng HC; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):252-7. PubMed ID: 27033389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
    North PE; Waner M; Mizeracki A; Mihm MC
    Hum Pathol; 2000 Jan; 31(1):11-22. PubMed ID: 10665907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations.
    Leon-Villapalos J; Wolfe K; Kangesu L
    Br J Plast Surg; 2005 Apr; 58(3):348-52. PubMed ID: 15780229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification of vascular tumors and malformations: basis for classification and clinical purpose].
    Moure C; Reynaert G; Lehmman P; Testelin S; Devauchelle B
    Rev Stomatol Chir Maxillofac; 2007 Jun; 108(3):201-9. PubMed ID: 17532354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Anomalies: Other Vascular Tumors.
    Atherton K; Hinen H
    Dermatol Clin; 2022 Oct; 40(4):401-423. PubMed ID: 36243428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma.
    Le Huu AR; Jokinen CH; Rubin BP; Mihm MC; Weiss SW; North PE; Dadras SS
    Am J Surg Pathol; 2010 Nov; 34(11):1563-73. PubMed ID: 20975337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular anomalies in children.
    Weibel L
    Vasa; 2011 Nov; 40(6):439-47. PubMed ID: 22090176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of GLUT1 as a diagnostic marker in cutaneous vascular anomalies: A review of literature and recommendations for daily practice.
    van Vugt LJ; van der Vleuten CJM; Flucke U; Blokx WAM
    Pathol Res Pract; 2017 Jun; 213(6):591-597. PubMed ID: 28552538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLUT-1 in oral benign vascular lesions.
    Johann AC; Salla JT; Gomez RS; de Aguiar MC; Gontijo B; Mesquita RA
    Oral Dis; 2007 Jan; 13(1):51-5. PubMed ID: 17241430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of 77 cases diagnosed as oral hemangiomas based on GLUT-1 positivity.
    da Silva Filho TJ; de Oliveira DHIP; Brasil VLM; Nonaka CFW; da Silveira ÉJD; Queiroz LMG
    Exp Mol Pathol; 2017 Aug; 103(1):9-13. PubMed ID: 28545938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the etiopathogenesis and differential diagnosis of oral vascular lesions by immunoexpression of GLUT-1 and HIF-1α.
    de Oliveira DH; da Silveira EJ; de Medeiros AM; Alves PM; Queiroz LM
    J Oral Pathol Med; 2014 Jan; 43(1):76-80. PubMed ID: 23734967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
    Johnson EF; Davis DM; Tollefson MM; Fritchie K; Gibson LE
    Am J Dermatopathol; 2018 Apr; 40(4):231-239. PubMed ID: 29561329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile Hemangiomas and Vascular Anomalies.
    Paradiso MM; Shah SD; Fernandez Faith E
    Pediatr Ann; 2024 Apr; 53(4):e129-e137. PubMed ID: 38574074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification of superficial vascular anomalies].
    Enjolras O; Soupre V; Picard A
    Presse Med; 2010 Apr; 39(4):457-64. PubMed ID: 20206462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute complications of vascular anomalies in childhood].
    Fließer M; Teichler A; Höger PH
    Hautarzt; 2017 Oct; 68(10):790-795. PubMed ID: 28815311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly involuting congenital hemangioma associated with profound, transient thrombocytopenia.
    Rangwala S; Wysong A; Tollefson MM; Khuu P; Benjamin LT; Bruckner AL
    Pediatr Dermatol; 2014; 31(3):402-4. PubMed ID: 22937785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.